| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.00e-04 | 645 | 46 | 8 | GO:0140640 | |
| GeneOntologyCellularComponent | IRE1-TRAF2-ASK1 complex | 2.83e-05 | 4 | 46 | 2 | GO:1990604 | |
| GeneOntologyCellularComponent | NURF complex | 9.88e-05 | 7 | 46 | 2 | GO:0016589 | |
| GeneOntologyCellularComponent | ISWI-type complex | 4.24e-04 | 14 | 46 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | Golgi membrane | 9.35e-04 | 721 | 46 | 7 | GO:0000139 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.78e-03 | 1293 | 46 | 9 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.83e-03 | 1299 | 46 | 9 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 2.12e-03 | 1327 | 46 | 9 | GO:0042175 | |
| Domain | SLIDE | 6.20e-06 | 2 | 47 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 6.20e-06 | 2 | 47 | 2 | IPR015194 | |
| Domain | SLIDE | 6.20e-06 | 2 | 47 | 2 | PF09111 | |
| Domain | HAND | 6.20e-06 | 2 | 47 | 2 | PF09110 | |
| Domain | ISWI | 6.20e-06 | 2 | 47 | 2 | IPR029915 | |
| Domain | PQQ | 1.86e-05 | 3 | 47 | 2 | PF01011 | |
| Domain | DBINO | 1.86e-05 | 3 | 47 | 2 | IPR020838 | |
| Domain | Ribonuc_2-5A | 1.86e-05 | 3 | 47 | 2 | PF06479 | |
| Domain | DBINO | 1.86e-05 | 3 | 47 | 2 | PF13892 | |
| Domain | KEN | 1.86e-05 | 3 | 47 | 2 | PS51392 | |
| Domain | KEN_dom | 1.86e-05 | 3 | 47 | 2 | IPR010513 | |
| Domain | PUG | 6.17e-05 | 5 | 47 | 2 | SM00580 | |
| Domain | PQQ | 9.24e-05 | 6 | 47 | 2 | SM00564 | |
| Domain | PUB_domain | 9.24e-05 | 6 | 47 | 2 | IPR018997 | |
| Domain | PQQ_beta_propeller_repeat | 9.24e-05 | 6 | 47 | 2 | IPR018391 | |
| Domain | PQQ_repeat | 9.24e-05 | 6 | 47 | 2 | IPR002372 | |
| Domain | - | 9.24e-05 | 6 | 47 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 9.24e-05 | 6 | 47 | 2 | IPR027295 | |
| Domain | DEAH_ATP_HELICASE | 1.18e-04 | 38 | 47 | 3 | PS00690 | |
| Domain | SANT_dom | 1.94e-03 | 26 | 47 | 2 | IPR017884 | |
| Domain | SANT | 2.25e-03 | 28 | 47 | 2 | PS51293 | |
| Domain | - | 2.46e-03 | 746 | 47 | 7 | 3.40.50.300 | |
| Domain | Helicase_C | 2.47e-03 | 107 | 47 | 3 | PF00271 | |
| Domain | HELICc | 2.47e-03 | 107 | 47 | 3 | SM00490 | |
| Domain | Helicase_C | 2.53e-03 | 108 | 47 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.60e-03 | 109 | 47 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.60e-03 | 109 | 47 | 3 | PS51192 | |
| Domain | DEXDc | 2.60e-03 | 109 | 47 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.67e-03 | 110 | 47 | 3 | IPR014001 | |
| Domain | SNF2_N | 2.93e-03 | 32 | 47 | 2 | PF00176 | |
| Domain | SNF2_N | 2.93e-03 | 32 | 47 | 2 | IPR000330 | |
| Domain | Ion_trans_dom | 2.95e-03 | 114 | 47 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.95e-03 | 114 | 47 | 3 | PF00520 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.50e-03 | 35 | 47 | 2 | IPR002464 | |
| Domain | P-loop_NTPase | 5.00e-03 | 848 | 47 | 7 | IPR027417 | |
| Domain | SANT | 7.03e-03 | 50 | 47 | 2 | SM00717 | |
| Domain | SANT/Myb | 7.59e-03 | 52 | 47 | 2 | IPR001005 | |
| Domain | Quinoprotein_ADH-like_supfam | 7.87e-03 | 53 | 47 | 2 | IPR011047 | |
| Domain | Channel_four-helix_dom | 9.06e-03 | 57 | 47 | 2 | IPR027359 | |
| Domain | - | 9.06e-03 | 57 | 47 | 2 | 1.20.120.350 | |
| Domain | Homeodomain-like | 9.59e-03 | 332 | 47 | 4 | IPR009057 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22315414 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16581782 | ||
| Pubmed | Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. | 1.79e-06 | 2 | 47 | 2 | 11175748 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 27774654 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12020828 | ||
| Pubmed | RNase domains determine the functional difference between IRE1alpha and IRE1beta. | 1.79e-06 | 2 | 47 | 2 | 18242182 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16950141 | ||
| Pubmed | Chromatin remodeling enzyme Snf2h regulates embryonic lens differentiation and denucleation. | 2.21e-06 | 19 | 47 | 3 | 27246713 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16973740 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 11850408 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 21738833 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 11359880 | ||
| Pubmed | Cloning of mammalian Ire1 reveals diversity in the ER stress responses. | 5.36e-06 | 3 | 47 | 2 | 9755171 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 10650002 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 29511123 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18369366 | ||
| Pubmed | The unfolded protein response: integrating stress signals through the stress sensor IRE1α. | 1.01e-05 | 31 | 47 | 3 | 22013210 | |
| Pubmed | Defective ATG16L1-mediated removal of IRE1α drives Crohn's disease-like ileitis. | 1.07e-05 | 4 | 47 | 2 | 28082357 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 20007910 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 18065414 | ||
| Pubmed | AIP1 is critical in transducing IRE1-mediated endoplasmic reticulum stress response. | 1.07e-05 | 4 | 47 | 2 | 18281285 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 12050113 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 24242955 | ||
| Pubmed | Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival. | 1.07e-05 | 4 | 47 | 2 | 28459443 | |
| Pubmed | Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis. | 1.78e-05 | 5 | 47 | 2 | 23942232 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 32758541 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 26106220 | ||
| Pubmed | WSTF-ISWI chromatin remodeling complex targets heterochromatic replication foci. | 2.67e-05 | 6 | 47 | 2 | 11980720 | |
| Pubmed | USP14 inhibits ER-associated degradation via interaction with IRE1alpha. | 2.67e-05 | 6 | 47 | 2 | 19135427 | |
| Pubmed | A GPI processing phospholipase A2, PGAP6, modulates Nodal signaling in embryos by shedding CRIPTO. | 3.74e-05 | 7 | 47 | 2 | 27881714 | |
| Pubmed | Dengue virus modulates the unfolded protein response in a time-dependent manner. | 4.98e-05 | 8 | 47 | 2 | 21385877 | |
| Pubmed | Molecular architecture of lineage allocation and tissue organization in early mouse embryo. | 4.98e-05 | 8 | 47 | 2 | 31391582 | |
| Pubmed | 5.16e-05 | 493 | 47 | 6 | 15368895 | ||
| Pubmed | A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. | 6.40e-05 | 9 | 47 | 2 | 16728976 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 8.19e-05 | 536 | 47 | 6 | 15840001 | |
| Pubmed | 8.34e-05 | 170 | 47 | 4 | 15057823 | ||
| Pubmed | 8.35e-05 | 538 | 47 | 6 | 10512203 | ||
| Pubmed | 2.12e-04 | 16 | 47 | 2 | 17903297 | ||
| Pubmed | EMC3 Is Essential for Retinal Organization and Neurogenesis During Mouse Retinal Development. | 2.12e-04 | 16 | 47 | 2 | 33605987 | |
| Pubmed | USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. | 2.70e-04 | 18 | 47 | 2 | 17846119 | |
| Pubmed | Snf2h Drives Chromatin Remodeling to Prime Upper Layer Cortical Neuron Development. | 3.69e-04 | 21 | 47 | 2 | 31680852 | |
| Pubmed | Large neutral amino acid levels tune perinatal neuronal excitability and survival. | 3.69e-04 | 21 | 47 | 2 | 36996814 | |
| Pubmed | CECR2 is involved in spermatogenesis and forms a complex with SNF2H in the testis. | 3.69e-04 | 21 | 47 | 2 | 22154806 | |
| Pubmed | 3.72e-04 | 103 | 47 | 3 | 32744500 | ||
| Pubmed | Differential expression and function of ABCG1 and ABCG4 during development and aging. | 4.06e-04 | 22 | 47 | 2 | 19633360 | |
| Pubmed | 4.84e-04 | 24 | 47 | 2 | 24946904 | ||
| Pubmed | Identification of proteins that interact with alpha A-crystallin using a human proteome microarray. | 5.54e-04 | 118 | 47 | 3 | 24453475 | |
| Pubmed | 7.05e-04 | 1116 | 47 | 7 | 31753913 | ||
| Pubmed | 7.09e-04 | 29 | 47 | 2 | 29543863 | ||
| Pubmed | 8.11e-04 | 31 | 47 | 2 | 21985497 | ||
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 8.64e-04 | 32 | 47 | 2 | 25189868 | |
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 9.19e-04 | 33 | 47 | 2 | 33567268 | |
| Pubmed | miR-195b is required for proper cellular homeostasis in the elderly. | 9.75e-04 | 34 | 47 | 2 | 38191655 | |
| Pubmed | 1.22e-03 | 38 | 47 | 2 | 22952603 | ||
| Pubmed | 1.35e-03 | 40 | 47 | 2 | 30865227 | ||
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.71e-03 | 53 | 31 | 2 | 532 | |
| GeneFamily | Ubiquitin specific peptidases | 4.14e-03 | 56 | 31 | 2 | 366 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-07 | 160 | 47 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-07 | 160 | 47 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 1.13e-06 | 175 | 47 | 5 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-06 | 185 | 47 | 5 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.44e-05 | 160 | 47 | 4 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 162 | 47 | 4 | 8ed9149ff53b285591354057055d072b203a47c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 162 | 47 | 4 | 7a05b05a33e1309fb5c0a8171db105ae68491815 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-05 | 164 | 47 | 4 | 76b0ac220b7ca22fbea28a507f01f96ae9f53932 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-05 | 164 | 47 | 4 | 911081739174ec68bc0893c804e4276b206bea7d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-05 | 164 | 47 | 4 | c5bfae7e9497185548c243d6f9ebadbcef48ba7f | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 3.16e-05 | 171 | 47 | 4 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 178 | 47 | 4 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 178 | 47 | 4 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-05 | 178 | 47 | 4 | fce60ce6b662f1bdaa3b4da43800c6c22fe89533 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-05 | 178 | 47 | 4 | b19c906e067b07eadfd68934d9330b447e24c708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 181 | 47 | 4 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 181 | 47 | 4 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 4.12e-05 | 183 | 47 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 186 | 47 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-05 | 187 | 47 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 188 | 47 | 4 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-05 | 191 | 47 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 191 | 47 | 4 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.87e-05 | 191 | 47 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 191 | 47 | 4 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 191 | 47 | 4 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 192 | 47 | 4 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 192 | 47 | 4 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 192 | 47 | 4 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-05 | 193 | 47 | 4 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.07e-05 | 193 | 47 | 4 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.17e-05 | 194 | 47 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.27e-05 | 195 | 47 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 196 | 47 | 4 | 2c3fbfbb08cd327cd97b3fa5a6f83b6d50771fb7 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.49e-05 | 197 | 47 | 4 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 5.60e-05 | 198 | 47 | 4 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | B_cells-Plasmablasts|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.60e-05 | 198 | 47 | 4 | c6cab47885be74a64351f843a741dea6d911bde4 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.60e-05 | 198 | 47 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-05 | 198 | 47 | 4 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | a8bfc0b93ad9968cf52a25be86995ffe436bd636 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.71e-05 | 199 | 47 | 4 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | normal_Pleural_Fluid-Epithelial_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.71e-05 | 199 | 47 | 4 | 564ba7acd03be2d6e4d0850cb2c7237a788dc275 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.71e-05 | 199 | 47 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 5.82e-05 | 200 | 47 | 4 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | 8f811ddd84c037a250d124496b0fbb2e4717011c | |
| ToppCell | mLN-Dendritic_cell-pDC|Dendritic_cell / Region, Cell class and subclass | 5.82e-05 | 200 | 47 | 4 | 10ae1ac8a98346320a92e855aebb3a7109f0ab9b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.40e-04 | 129 | 47 | 3 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-04 | 130 | 47 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-04 | 132 | 47 | 3 | 14a512f433315892bf0326419f23d0d5919d01ec | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.24e-04 | 139 | 47 | 3 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-04 | 139 | 47 | 3 | 6396434c1cb209193ccdf15581ec2adacf941d85 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-04 | 143 | 47 | 3 | bb8d4c335682d1a6798bed0de8bb0603054a4944 | |
| ToppCell | ASK454-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.70e-04 | 144 | 47 | 3 | 8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 145 | 47 | 3 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-04 | 146 | 47 | 3 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.39e-04 | 151 | 47 | 3 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 152 | 47 | 3 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 5.60e-04 | 153 | 47 | 3 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.60e-04 | 153 | 47 | 3 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.15e-04 | 158 | 47 | 3 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-04 | 159 | 47 | 3 | 5543f5aec6352a7c5923e55daf3ed40ff5cc0f0c | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-04 | 159 | 47 | 3 | f0611a7bf15e2f7dfe828dd247650a30b3d6d44d | |
| ToppCell | LAM-Lymphoid-B-cell-2|LAM / Condition, Lineage and Cell class | 6.38e-04 | 160 | 47 | 3 | 0060c2b3304f411c682aa2ba20bcf80f346d2403 | |
| ToppCell | Control-APC-like-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 6.38e-04 | 160 | 47 | 3 | 463dd624ca5c375b6ff7c269f4ef4b9d74f4b669 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-04 | 160 | 47 | 3 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-04 | 160 | 47 | 3 | 21f7c0337fbd99e4a20650920d8302d7318bd25e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-04 | 161 | 47 | 3 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | facs-SCAT-Fat-18m-Epithelial-epithelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-04 | 162 | 47 | 3 | 7215f6eb2b65dea455e2eec722a9c38e6958b120 | |
| ToppCell | facs-SCAT-Fat-18m-Epithelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-04 | 162 | 47 | 3 | 7fa93efa2039d68a4e8214fa143bcd3368349a2d | |
| ToppCell | facs-SCAT-Fat-18m-Epithelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-04 | 162 | 47 | 3 | 341fa357ad7bdbef30864e8062f161e60185ffc9 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.73e-04 | 163 | 47 | 3 | 22fa5d017ff796394394d952ec151e2d1beb8248 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 6.73e-04 | 163 | 47 | 3 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 163 | 47 | 3 | 8509b87748ec460992ae6cedbb155e1c6f6e2e48 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 163 | 47 | 3 | e04de78a52cc886623689a913f7852200a77605b | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.85e-04 | 164 | 47 | 3 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-04 | 164 | 47 | 3 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-04 | 164 | 47 | 3 | 875d922eec7e3df0998ddf0c8c4dee2dcd5b23ca | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.98e-04 | 165 | 47 | 3 | e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.22e-04 | 167 | 47 | 3 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-04 | 167 | 47 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-04 | 167 | 47 | 3 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.35e-04 | 168 | 47 | 3 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.35e-04 | 168 | 47 | 3 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.35e-04 | 168 | 47 | 3 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | bc7d5f0e5d222922eaf1c8e8c87aab189209d6b6 | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.48e-04 | 169 | 47 | 3 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 7.48e-04 | 169 | 47 | 3 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.48e-04 | 169 | 47 | 3 | 150c08c7b1dc0f46173a7b8f6a3fc70d82906c0d | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.48e-04 | 169 | 47 | 3 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-04 | 170 | 47 | 3 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.61e-04 | 170 | 47 | 3 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-04 | 170 | 47 | 3 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| Disease | Generalized hypotonia | 2.57e-04 | 15 | 47 | 2 | C1858120 | |
| Disease | central nervous system disease (implicated_via_orthology) | 2.94e-04 | 16 | 47 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | PR interval | 1.12e-03 | 495 | 47 | 5 | EFO_0004462 | |
| Disease | Global developmental delay | 1.26e-03 | 133 | 47 | 3 | C0557874 | |
| Disease | fetal genotype effect measurement, body weights and measures | 2.78e-03 | 49 | 47 | 2 | EFO_0004324, EFO_0007959 | |
| Disease | smooth surface dental caries | 4.42e-03 | 62 | 47 | 2 | EFO_0006339 | |
| Disease | Colorectal Carcinoma | 5.05e-03 | 702 | 47 | 5 | C0009402 | |
| Disease | Seizures | 5.08e-03 | 218 | 47 | 3 | C0036572 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 5.44e-03 | 69 | 47 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.54e-03 | 447 | 47 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 5.54e-03 | 447 | 47 | 4 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFSWTFLGRNVFNKF | 196 | Q86UK0 | |
| FQFRTWNKAGLLLFS | 396 | Q9C0A0 | |
| RNVNKQWITFQHFSF | 41 | Q12887 | |
| KFQVWRLVTNFLFFG | 51 | Q96Q80 | |
| NRQSFQYKTWTFVVS | 1456 | Q00975 | |
| QRFKAFNQRFLWFLQ | 251 | P05177 | |
| SWKQRLFIINFISFF | 181 | Q9UHJ9 | |
| SFRFFWIQNVSLKFQ | 46 | Q14667 | |
| SRAVSLFFNWKQEFR | 646 | Q9NPP4 | |
| FWSRAKQLQFFQDVS | 781 | Q76MJ5 | |
| QAWKSFLNVAIFQHF | 21 | Q8NCR3 | |
| YQKFFNFVLKWQRSE | 686 | Q6ZR08 | |
| KDIFSVINFFSFFNW | 391 | Q01650 | |
| IFFGTAQNFWKILST | 1596 | P50748 | |
| NFQLALNFAWSNFRF | 36 | Q96RT8 | |
| WNFDFSIFNKSLRLN | 341 | Q8IWF2 | |
| IIFKNATFTFTWAFQ | 556 | A8MWY0 | |
| LFTAKFFNANQWADI | 106 | Q9BTY2 | |
| FFWSLEKQLQFFQDV | 831 | O75460 | |
| VFQGFTKINAFNWAK | 251 | Q9Y4F1 | |
| FYNQQTLKWKIFTNF | 186 | P51685 | |
| RIETAQQFFSWFAKL | 101 | Q96JB2 | |
| SFFNLTLKQVLFLQW | 181 | Q9Y2A9 | |
| GINTWQFNFKFNLTE | 91 | Q9UFF9 | |
| FIQVNQFALASHFFW | 396 | Q9HBU6 | |
| WTFFERLQRFQNLKT | 61 | Q14147 | |
| EFKKRWTQFVNVTFQ | 656 | Q8IZU8 | |
| DRIFFGQWTLVQFNF | 276 | Q92521 | |
| GQWTLVQFNFLKFNV | 281 | Q92521 | |
| FNFCALTFNKFWGTI | 186 | Q9P1P4 | |
| SKNVRFWFAHNVLFN | 2081 | Q93008 | |
| FWFAHNVLFNVSNRF | 2086 | Q93008 | |
| GFTNWTKRDFNQFIK | 856 | P28370 | |
| QNWTFAFDFSFLSQQ | 71 | Q96S42 | |
| ITSQLIKWFSNFREF | 616 | Q92786 | |
| QTATAQLRKFTEWFF | 1701 | Q9P2F8 | |
| QFDWKLINVFFSNAS | 161 | Q6P1J6 | |
| FFRFNSLSNWRKCNT | 16 | Q96E52 | |
| TFFIFLNKTFQWPNS | 451 | Q5BKT4 | |
| EFLAFKNDIQFWNSR | 371 | O96005 | |
| TFWNFIPKNLFEQFR | 56 | P98196 | |
| WFRTQNQVLFFFAAI | 226 | Q5BKX6 | |
| FFEVKSISNQVWKFQ | 1141 | Q9HCF6 | |
| NAFFLVKFWADLNTN | 291 | Q15561 | |
| FFFWFNTSFIQNNRL | 476 | Q6XPS3 | |
| NFLRWLLKFNIFSFI | 451 | Q6UXY8 | |
| IFWANLKAFVQFVFD | 986 | Q13395 | |
| GFTNWNKRDFNQFIK | 841 | O60264 | |
| AAIQNGFWFFKFLIL | 126 | Q96SA4 | |
| FRNWLFLNKDAFTFS | 146 | Q8NFA0 | |
| ANFRAWKTKFISQLQ | 181 | Q6NUM6 |